Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 5 minute read Pharma Industry News Can Japanese patent leverage strengthen Annamycin’s hand in AML? Moleculin Biotech secures Japanese patent for Annamycin. Explore how this IP move could shape AML strategy and global commercialization plans. bySoujanya RaviFebruary 20, 2026